How to buy INC Research stock
Learn how to easily invest in INC Research stock.
INC Research is a diagnostics & research business based in the US. INC Research shares (SYNH) are listed on the NASDAQ and all prices are listed in US Dollars. INC Research employs 28,768 staff and has a trailing 12-month revenue of around $5.4 billion.
How to buy INC Research stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SYNH. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
INC Research stock price (NASDAQ: SYNH)Use our graph to track the performance of SYNH stocks over time.
INC Research shares at a glance
|Latest market close||$42.78|
|52-week range||$22.89 - $52.23|
|50-day moving average||$42.40|
|200-day moving average||$38.65|
|Wall St. target price||$42.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.70|
Buy INC Research stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy INC Research stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
INC Research price performance over time
|1 week (2023-09-15)||0.09%|
|1 month (2023-08-22)||0.64%|
|3 months (2023-06-22)||2.52%|
|6 months (2023-03-22)||26.42%|
|1 year (2022-09-18)||N/A|
|2 years (2021-09-22)||-55.10%|
|3 years (2020-09-22)||54.48|
|5 years (2018-09-21)||49.1|
Is INC Research stock undervalued or overvalued?
Valuing INC Research stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of INC Research's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
INC Research's P/E ratio
INC Research's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 61x. In other words, INC Research shares trade at around 61x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
INC Research's PEG ratio
INC Research's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2799. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into INC Research's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
INC Research's EBITDA
INC Research's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $587.5 million.
The EBITDA is a measure of a INC Research's overall financial performance and is widely used to measure a its profitability.
INC Research financials
|Revenue TTM||$5.4 billion|
|Operating margin TTM||6.33%|
|Gross profit TTM||$1.3 billion|
|Return on assets TTM||2.63%|
|Return on equity TTM||2.09%|
|Market Capitalization||$4.4 billion|
TTM: trailing 12 months
INC Research share dividends
We're not expecting INC Research to pay a dividend over the next 12 months.
INC Research share price volatility
Over the last 12 months, INC Research's shares have ranged in value from as little as $22.8941 up to $52.23. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while INC Research's is 1.5826. This would suggest that INC Research's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
INC Research overview
Syneos Health, Inc. , operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries.
INC Research in the news
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Syneos Health, Inc. (SYNH) Investors of a Class Action Lawsuit and Upcoming Deadline
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Syneos Health, Inc. (SYNH)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Syneos Investors of a Lead Plaintiff Deadline of September 25, 2023
Frequently asked questionsWhat percentage of INC Research is owned by insiders or institutions?
Currently 0.485% of INC Research shares are held by insiders and 94.745% by institutions. How many people work for INC Research?
Latest data suggests 28,768 work at INC Research. When does the fiscal year end for INC Research?
INC Research's fiscal year ends in December. Where is INC Research based?
INC Research's address is: 1030 Sync Street, Morrisville, NC, United States, 27560-5468 What is INC Research's ISIN number?
INC Research's international securities identification number is: US87166B1026 What is INC Research's CUSIP number?
INC Research's Committee on Uniform Securities Identification Procedures number is: 87166B102
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert